Literature DB >> 30130745

Diagnostic Yield of Computed Tomography-Guided Transthoracic Lung Biopsy in Diffuse Lung Diseases.

Eva Padrão1, Márcio Rodrigues2, Susana Guimarães3, Patrícia Caetano Mota1,4, Natália Melo1, Conceição Souto Moura3,4, António Morais1,4, José Miguel Pereira2,4.   

Abstract

BACKGROUND: Accurate diagnosis is essential for successful management of diffuse lung disease (DLD). Histopathology may sometimes be necessary. Surgical lung biopsy, the gold standard, carries a risk of morbidity and mortality. Computed tomography (CT) guided transthoracic lung biopsy (CT-TLB) is a minimally invasive method for obtaining lung tissue. However, its diagnostic yield is unknown in DLD.
OBJECTIVE: To assess the diagnostic yield of CT-TLB in DLD according to the predominant high-resolution CT (HRCT) patterns.
METHODS: Between January 2009 and December 2016, we enrolled all consecutive adult patients with suspicion of DLD who underwent CT-guided transthoracic lung biopsy during the diagnostic work-up. All biopsies were performed by a senior interventional radiologist using CT fluoroscopy.
RESULTS: The study included 169 patients (50.3% men) with a mean (±SD) age of 58.3 ± 14 years. Consolidation was the predominant HRCT pattern. A definitive or probable diagnosis was made in 66.3%. The most frequent diagnosis was organizing pneumonia (36.2%). Diagnostic yield was higher when the predominant HRCT pattern was consolidation or nodular. The most common complication was pneumothorax (17.8%); other complications included mild hemoptysis (7.7%), hemothorax (1.2%), and death (0.59%). No acute exacerbation of the underlying condition was observed.
CONCLUSIONS: CT-TLB proved to be accurate and safe for the diagnosis of DLD. The overall diagnostic yield of the procedure was 66.3%. Given its low complication rates, CT-TLB can be an option in patients whose respiratory function is seriously impaired and in those with substantial comorbidities, where more invasive procedures cannot be performed for reasons of safety.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Complications; Computed tomography-guided transthoracic lung biopsy ; Diagnostic yield; Diffuse lung diseases; Organizing pneumonia; Surgical lung biopsy

Mesh:

Year:  2018        PMID: 30130745     DOI: 10.1159/000489934

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  4 in total

1.  Outcomes for Elective Open and Thoracoscopic Surgical Lung Biopsies in the United States and Temporal Trends.

Authors:  Bilal F Samhouri; Amjad N Kanj; Omar Chehab; Jay H Ryu
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2022-02-04

2.  Improving CT-guided transthoracic biopsy diagnostic yield of lung masses using intraprocedural CT and prior PET/CT fusion imaging.

Authors:  Yue Lin; Yanyan Xu; Jie Lin; Liping Fu; Hongliang Sun; Zhenguo Huang; Bee Yen Ooi; Sheng Xie
Journal:  BMC Pulm Med       Date:  2022-08-13       Impact factor: 3.320

3.  Clinical Implications of "Atypia" on Biopsy: Possible Precursor to Lung Cancer?

Authors:  Denise Albano; Lee Ann Santore; Thomas Bilfinger; Melissa Feraca; Samantha Novotny; Barbara Nemesure
Journal:  Curr Oncol       Date:  2021-07-06       Impact factor: 3.677

4.  Diagnostic Yield of Transbronchial Cryobiopsy Guided by Radial Endobronchial Ultrasound and Fluoroscopy in the Radiologically Suspected Lung Cancer: A Single Institution Prospective Study.

Authors:  Vytautas Ankudavicius; Skaidrius Miliauskas; Lina Poskiene; Donatas Vajauskas; Marius Zemaitis
Journal:  Cancers (Basel)       Date:  2022-03-18       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.